Sheldon B. Taubman

488 total citations
15 papers, 380 citations indexed

About

Sheldon B. Taubman is a scholar working on Molecular Biology, Immunology and Periodontics. According to data from OpenAlex, Sheldon B. Taubman has authored 15 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Immunology and 3 papers in Periodontics. Recurrent topics in Sheldon B. Taubman's work include Complement system in diseases (3 papers), Microbial Natural Products and Biosynthesis (2 papers) and Erythrocyte Function and Pathophysiology (2 papers). Sheldon B. Taubman is often cited by papers focused on Complement system in diseases (3 papers), Microbial Natural Products and Biosynthesis (2 papers) and Erythrocyte Function and Pathophysiology (2 papers). Sheldon B. Taubman collaborates with scholars based in United States and United Kingdom. Sheldon B. Taubman's co-authors include Ronald B. Cogen, John W. Corcoran, Irwin H. Lepow, Frank E. Young, Toshi Kaneda, John C. Butte, Richard A. Patrick, Sarkis H. Ohanian, G. J. Thorbecke and F. William Sunderman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and JNCI Journal of the National Cancer Institute.

In The Last Decade

Sheldon B. Taubman

15 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheldon B. Taubman United States 10 156 66 56 47 35 15 380
R Niedner Germany 13 104 0.7× 111 1.7× 17 0.3× 19 0.4× 48 1.4× 45 687
Marcelo H. Grunwald Israel 17 72 0.5× 51 0.8× 42 0.8× 57 1.2× 20 0.6× 51 797
Robert E. Kellum United States 16 118 0.8× 91 1.4× 50 0.9× 8 0.2× 11 0.3× 32 696
M. J. Shear United States 15 152 1.0× 240 3.6× 10 0.2× 31 0.7× 37 1.1× 31 573
J. Michalski Poland 15 61 0.4× 140 2.1× 50 0.9× 14 0.3× 100 2.9× 51 685
S Tomlin United Kingdom 8 85 0.5× 40 0.6× 17 0.3× 11 0.2× 14 0.4× 18 340
Mary A. Smal Australia 11 77 0.5× 57 0.9× 20 0.4× 86 1.8× 19 0.5× 25 327
Yasumasa Sato Japan 13 103 0.7× 38 0.6× 11 0.2× 28 0.6× 15 0.4× 44 398
Charles F. Lange United States 11 255 1.6× 69 1.0× 10 0.2× 17 0.4× 6 0.2× 38 512
E Zdebska Poland 17 497 3.2× 115 1.7× 59 1.1× 10 0.2× 184 5.3× 57 833

Countries citing papers authored by Sheldon B. Taubman

Since Specialization
Citations

This map shows the geographic impact of Sheldon B. Taubman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheldon B. Taubman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheldon B. Taubman more than expected).

Fields of papers citing papers by Sheldon B. Taubman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheldon B. Taubman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheldon B. Taubman. The network helps show where Sheldon B. Taubman may publish in the future.

Co-authorship network of co-authors of Sheldon B. Taubman

This figure shows the co-authorship network connecting the top 25 collaborators of Sheldon B. Taubman. A scholar is included among the top collaborators of Sheldon B. Taubman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheldon B. Taubman. Sheldon B. Taubman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Cogen, Ronald B. & Sheldon B. Taubman. (1982). Cellular effects of human leukocyte hydrolases I. Human gingival fibroblasts. Journal of Oral Pathology and Medicine. 11(4). 290–299. 3 indexed citations
2.
Cogen, Ronald B., Sheldon B. Taubman, & Peter Goldblatt. (1982). Cellular effects of human leukocyte hydrolases II. Ultrastructural studies on fibroblasts. Journal of Oral Pathology and Medicine. 11(4). 300–309. 5 indexed citations
3.
Cogen, Ronald B., Sheldon B. Taubman, & Edward G. D. Tuddenham. (1981). Detachment of Endothelial Cells by Polymorphonuclear Leukocytes in Vitro: Potentiation by Antibody Coating and Prevention by Inflammatory Exudate. Journal of Periodontology. 52(11). 668–672. 5 indexed citations
4.
Sunderman, F. William, et al.. (1980). Manganese inhibition of sarcoma induction by benzo[a]pyrene in rats. Carcinogenesis. 1(7). 613–620. 10 indexed citations
5.
Taubman, Sheldon B. & Robert M. Nakamura. (1979). Screening Tests for Cell-Mediated Immunodeficiency Diseases. CRC Critical Reviews in Clinical Laboratory Sciences. 11(3). 207–244. 1 indexed citations
6.
Cogen, Ronald B., et al.. (1977). Cytopathologic Effects of Chlorhexidine on Human Cells. Journal of Periodontology. 48(4). 212–215. 86 indexed citations
7.
Taubman, Sheldon B.. (1975). Interaction of Cls and C4. A binding phenomenon. Biochimica et Biophysica Acta (BBA) - Protein Structure. 393(2). 542–555. 2 indexed citations
8.
Taubman, Sheldon B. & Ronald B. Cogen. (1974). Granule Enzymes from Human Leukocytes: Their Effect on HeLa Cells. Experimental Biology and Medicine. 145(3). 952–957. 16 indexed citations
9.
Taubman, Sheldon B. & Irwin H. Lepow. (1971). Cleavage of human by human lysosomal enzymes, plasmin, and trypsin. Immunochemistry. 8(10). 951–961. 20 indexed citations
10.
Taubman, Sheldon B., et al.. (1970). Effects of lysosomal enzymes from human leukocytes on human complement components. Federation Proceedings. 29(2). 434. 18 indexed citations
11.
Patrick, Richard A., Sheldon B. Taubman, & Irwin H. Lepow. (1970). Cleavage of the fourth component of human complement (C4) by activated activated Cls. Immunochemistry. 7(2). 217–225. 32 indexed citations
12.
Ohanian, Sarkis H., Sheldon B. Taubman, & G. J. Thorbecke. (1969). Rates of Albumin and Transferrin Synthesis <italic>In Vitro</italic> in Rat Hepatoma-Derived H<sub>4</sub> II-EC<sub>3</sub> Cells<xref ref-type="fn" rid="FN2">2</xref>. JNCI Journal of the National Cancer Institute. 43(2). 397–406. 22 indexed citations
13.
Taubman, Sheldon B., et al.. (1966). Sensitivity and resistance to erythromycin in Bacillus subtilis 168: The ribosomal binding of erythromycin and chloramphenicol. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 123(2). 438–440. 82 indexed citations
14.
Taubman, Sheldon B., Frank E. Young, & John W. Corcoran. (1963). ANTIBIOTIC GLYCOSIDES, IV. STUDIES ON THE MECHANISM OF ERYTHROMYCIN RESISTANCE IN BACILLUS SUBTILIS. Proceedings of the National Academy of Sciences. 50(5). 955–962. 13 indexed citations
15.
Kaneda, Toshi, John C. Butte, Sheldon B. Taubman, & John W. Corcoran. (1962). Actinomycete Antibiotics. Journal of Biological Chemistry. 237(2). 322–328. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026